Oncology
 |
|
11 december 2018 17:00:04 |
| The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations (BMC Cancer) |
|
Tweet The EGFR-T790M mutation is clinically detected using re-biopsy in approximately 50% of patients with acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in advanced non-... |
| 83 viewsCategory: Oncology |
 SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma (BMC Cancer)A banner year for immunotherapy and targeted therapy (Nature Clinical Practice Oncology) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
